Generic Drug Price Inflation Tackled In Congressional Budget Deal
This article was originally published in The Pink Sheet Daily
Executive Summary
A provision in the Bipartisan Budget Act of 2015 will require that generic drug manufacturers pay additional rebates to Medicaid if prices increase faster than inflation, as manufacturers of single-source brands do.